ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

NBIX Neurocrine Biosciences Inc

137.95
0.12 (0.09%)
Last Updated: 12:32:21
Delayed by 15 minutes

Period:

Draw Mode:

Volume 316,528
Bid Price 137.90
Ask Price 138.00
News (1)
Day High 138.72

Low
89.04

52 Week Range

High
148.3699

Day Low 135.97
Company Name Stock Ticker Symbol Market Type
Neurocrine Biosciences Inc NBIX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.12 0.09% 137.95 12:32:21
Open Price Low Price High Price Close Price Prev Close
137.83 135.97 138.72 137.83
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
7,136 316,528 $ 137.73 $ 43,596,531 - 89.04 - 148.3699
Last Trade Time Type Quantity Stock Price Currency
12:32:21 5 $ 137.955 USD

Neurocrine Biosciences (NBIX) Options Flow Summary

Overall Flow

Bullish

Net Premium

84k

Calls / Puts

100.00%

Buys / Sells

100.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

Neurocrine Biosciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
13.71B 99.51M - 1.89B 249.7M 2.51 54.89
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Neurocrine Biosciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No NBIX Message Board. Create One! See More Posts on NBIX Message Board See More Message Board Posts

Historical NBIX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week140.05148.3699133.425141.571,150,750-2.10-1.50%
1 Month135.51148.3699129.15137.871,023,5902.441.80%
3 Months132.92148.3699128.00136.75877,5525.033.78%
6 Months115.15148.3699103.63126.73790,77122.8019.80%
1 Year96.83148.369989.04114.45754,78341.1242.47%
3 Years98.42148.369971.875102.97782,71339.5340.16%
5 Years85.16148.369971.85102.08801,36352.7961.99%

Neurocrine Biosciences Description

Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.

Your Recent History

Delayed Upgrade Clock